Ignite Creation Date:
2025-12-24 @ 11:45 AM
Ignite Modification Date:
2026-03-26 @ 11:51 AM
Study NCT ID:
NCT03227861
Status:
COMPLETED
Last Update Posted:
2025-02-04
First Post:
2017-07-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care
Sponsor:
Janssen Scientific Affairs, LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR108345
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None